Analyzing DS Healthcare Group (DSKX) and Its Competitors

DS Healthcare Group (OTCMKTS: DSKX) is one of 32 public companies in the “Personal Products” industry, but how does it weigh in compared to its peers? We will compare DS Healthcare Group to related businesses based on the strength of its institutional ownership, earnings, profitability, dividends, risk, valuation and analyst recommendations.

Volatility and Risk

DS Healthcare Group has a beta of 2.31, meaning that its share price is 131% more volatile than the S&P 500. Comparatively, DS Healthcare Group’s peers have a beta of 1.24, meaning that their average share price is 24% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for DS Healthcare Group and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DS Healthcare Group 0 0 0 0 N/A
DS Healthcare Group Competitors 369 1288 1546 24 2.38

As a group, “Personal Products” companies have a potential upside of 12.57%. Given DS Healthcare Group’s peers higher probable upside, analysts clearly believe DS Healthcare Group has less favorable growth aspects than its peers.

Valuation and Earnings

This table compares DS Healthcare Group and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
DS Healthcare Group $12.95 million -$6.93 million -0.02
DS Healthcare Group Competitors $16.34 billion $2.21 billion 396.21

DS Healthcare Group’s peers have higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

0.0% of DS Healthcare Group shares are held by institutional investors. Comparatively, 56.8% of shares of all “Personal Products” companies are held by institutional investors. 19.4% of DS Healthcare Group shares are held by company insiders. Comparatively, 15.4% of shares of all “Personal Products” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares DS Healthcare Group and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DS Healthcare Group -62.31% -1,304.25% -117.85%
DS Healthcare Group Competitors -24.47% 76.89% 1.30%

Summary

DS Healthcare Group peers beat DS Healthcare Group on 8 of the 10 factors compared.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for DS Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply